ImpediMed target price cut to A$0.009
Morgans cut its ImpediMed target price by 10% to A$0.009 per share.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Morgans cut its ImpediMed target price by 10% to A$0.009 per share.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.